Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung

Japanese Journal of Clinical Oncology

Volumn 39, Issue 1, 2009, Pages 33-36

  Ishihama, Hiromi ^a   Chida, Masayuki ^a   Araki, Osamu ^a   Karube, Yoko ^a   Seki, Norio ^a   Tamura, Motohiko ^a   Umezu, Hideo ^a   Honma, Koichi ^a   Masawa, Nobuhide ^a   Miyoshi, Shinichiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Gene expression; Lung cancer; Orotate phosphoribosyl transferase; Thymidylate synthase; UFT

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; MESSENGER RNA; OROTATE PHOSPHORIBOSYLTRANSFERASE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; UFT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; OROTATE PHOSPHORIBOSYLTRANSFERASE; PROGNOSIS; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

EID: 58149396155     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn121     Document Type: Article

References (11)

1. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 1997;15:3223-9.
2. Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, et al. High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res 1998;4:2371-6.
3. Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clinical Cancer Res 2000;6:1322-7.
4. Oguri T, Achiwa H, Bessho Y, Muramatsu H, Maeda H, Nimn T, et al. The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells. Lung Cancer 2005;49:345-51.
5. Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Wada H, et al. Meta-analysis of postoperative chemotherapy with Tegafur-Uracil in non-small-cell lung cancer. J Clin Oncol 2005;23:4999-5007.
6. Sobin LH, Wittenkind C. TNM classification of malignant tumors. New York: Wiley-Liss 1997.
7. Fink L, Seege W, Ermert L, Hänze J, Stahl U, Grimminger F, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998;4:1329-33.
8. Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, et al. New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction. Int J Cancer 2003;104:790-5.
9. Takahashi T. Expression of orotate phosphoribosyltransferase in colorectal cancer. Med Soc Saitama Med Sch 2004;31:45-50.
10. Masakazu F, Yousuke F, Yoshikazu S. Population study of thymidylate synthase dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in patients with solid tumors. Proceedings of the 47th AACR, 2006;854.
11. Tatsumi K, Fukushima M, Shirasaka T, Fujii S. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluoro-uracil degradation in rat liver extracts. Jpn J Cancer Res 1981;78:748-55.